Expression of RAN in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RAN is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 693.22

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

734.7

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	1414.8
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	1346.8
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	1266.6
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	1255.1
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	1217.9
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	1132.0
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	1065.8
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	1063.8
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	1059.5
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	1040.0
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	1026.8
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	1017.3
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	999.0
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	971.7
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	959.1
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	956.2
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	949.4
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	948.5
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	946.4
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	937.2
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	936.1
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	932.7
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	927.2
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	919.4
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	919.1
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	909.5
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	899.1
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	895.4
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	883.3
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	880.2
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	873.4
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	870.6
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	869.7
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	860.4
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	857.7
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	857.3
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	851.4
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	846.9
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	845.9
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	841.1
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	837.9
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	829.5
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	826.6
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	821.4
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	821.3
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	816.4
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	807.3
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	807.1
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	794.7
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	784.5
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	781.8
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	778.7
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	778.0
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	764.7
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	761.7
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	746.4
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	741.0
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	738.0
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	733.1
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	731.2
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	730.9
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	730.5
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	730.1
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	722.7
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	717.3
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	714.7
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	713.8
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	712.9
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	706.1
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	701.5
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	695.8
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	693.2
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	690.5
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	689.9
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	687.7
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	687.5
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	686.0
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	684.7
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	679.5
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	677.0
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	674.0
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	673.0
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	672.9
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	668.9
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	667.2
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	665.3
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	664.4
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	659.3
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	653.6
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	646.8
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	644.1
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	642.1
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	638.0
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	637.8
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	633.1
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	629.4
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	629.1
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	628.7
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	624.1
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	623.0
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	623.0
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	619.5
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	617.1
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	612.8
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	607.9
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	606.0
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	605.8
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	605.7
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	600.7
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	593.6
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	576.1
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	574.3
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	573.0
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	566.7
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	564.1
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	559.5
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	559.5
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	558.0
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	555.1
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	546.3
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	539.3
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	534.8
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	532.2
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	529.2
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	525.0
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	516.0
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	515.8
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	515.8
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	512.5
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	505.0
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	498.3
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	492.3
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	489.2
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	481.4
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	465.9
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	461.0
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	384.4
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	381.7
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	370.4
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	341.0
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	304.5
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RAN is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 234

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

285.9

Number of samples

Samples

Sample	Description	pTPM
AK156	N, NA, stage:NA, dead, 330 days	533.5
AK043	N, NA, stage:NA, alive, 660 days	409.0
AK199	N, NA, stage:NA, alive, 1860 days	401.3
AK124	N, NA, stage:NA, alive, 1920 days	399.9
AK142	N, NA, stage:NA, alive, 90 days	376.9
AK074	N, NA, stage:NA, alive, 300 days	358.3
AK231	N, NA, stage:NA, dead, 240 days	355.8
AK002	N, NA, stage:NA, dead, 570 days	355.5
AK173	N, NA, stage:NA, dead, 180 days	353.0
AK165	N, NA, stage:NA, alive, 360 days	352.3
AK133	N, NA, stage:NA, dead, 360 days	352.1
AK236	N, NA, stage:NA, dead, 360 days	350.1
AK081	N, NA, stage:NA, dead, 180 days	334.6
AK068	N, NA, stage:NA, alive, 360 days	333.5
AK072	N, NA, stage:NA, dead, 150 days	321.5
AK185	N, NA, stage:NA, alive, 330 days	316.3
AK071	N, NA, stage:NA, dead, 540 days	312.4
AK098	N, NA, stage:NA, dead, 660 days	310.4
AK051	N, NA, stage:NA, dead, 360 days	309.9
AK183	N, NA, stage:NA, alive, 360 days	309.2
AK227	N, NA, stage:NA, alive, 300 days	306.7
AK216	N, NA, stage:NA, dead, 360 days	304.3
AK123	N, NA, stage:NA, dead, 180 days	304.0
AK153	N, NA, stage:NA, dead, 240 days	293.1
AK158	N, NA, stage:NA, dead, 360 days	293.0
AK149	N, NA, stage:NA, dead, 420 days	278.7
AK053	N, NA, stage:NA, dead, 300 days	276.4
AK117	N, NA, stage:NA, dead, 210 days	275.3
AK195	N, NA, stage:NA, dead, 390 days	275.0
AK213	N, NA, stage:NA, alive, 2010 days	272.7
AK100	N, NA, stage:NA, alive, 960 days	271.9
AK055	N, NA, stage:NA, dead, 240 days	266.4
AK079	N, NA, stage:NA, dead, 210 days	265.4
AK066	N, NA, stage:NA, alive, 960 days	262.4
AK035	N, NA, stage:NA, dead, 210 days	261.2
AK089	N, NA, stage:NA, dead, 330 days	260.6
AK049	N, NA, stage:NA, dead, 180 days	258.7
AK003	N, NA, stage:NA, dead, 600 days	258.4
AK085	N, NA, stage:NA, alive, 660 days	256.2
AK134	N, NA, stage:NA, dead, 360 days	252.5
AK188	N, NA, stage:NA, alive, 420 days	251.8
AK076	N, NA, stage:NA, alive, 660 days	250.5
AK099	N, NA, stage:NA, dead, 420 days	248.1
AK178	N, NA, stage:NA, dead, 240 days	245.6
AK006	N, NA, stage:NA, dead, 360 days	234.5
AK015	N, NA, stage:NA, alive, 720 days	234.3
AK218	N, NA, stage:NA, dead, 180 days	233.7
AK088	N, NA, stage:NA, dead, 360 days	230.4
AK139	N, NA, stage:NA, dead, 270 days	230.0
AK041	N, NA, stage:NA, alive, 810 days	225.8
AK103	N, NA, stage:NA, alive, 1320 days	225.6
AK226	N, NA, stage:NA, dead, 360 days	224.2
AK167	N, NA, stage:NA, dead, 180 days	214.1
AK030	N, NA, stage:NA, dead, 120 days	207.2
AK205	N, NA, stage:NA, dead, 120 days	186.6
AK091	N, NA, stage:NA, dead, 210 days	183.3
AK102	N, NA, stage:NA, alive, 1740 days	177.2
AK005	N, NA, stage:NA, dead, 240 days	141.1
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0217000004	Tumor	1.2
CPT0206230003	Tumor	0.9
CPT0189460003	Tumor	0.8
CPT0206110003	Tumor	0.7
CPT0162100003	Tumor	0.6
CPT0087730003	Tumor	0.6
CPT0205570003	Tumor	0.6
CPT0125570003	Tumor	0.6
CPT0189650004	Tumor	0.6
CPT0219080004	Tumor	0.6
CPT0162020003	Tumor	0.5
CPT0221180003	Tumor	0.5
CPT0087570003	Tumor	0.5
CPT0168380003	Tumor	0.5
CPT0078580003	Tumor	0.4
CPT0087950003	Tumor	0.4
CPT0205780003	Tumor	0.4
CPT0206560003	Tumor	0.4
CPT0206780003	Tumor	0.4
CPT0175060003	Tumor	0.3
CPT0064650003	Tumor	0.3
CPT0205450004	Tumor	0.3
CPT0206880003	Tumor	0.3
CPT0218770003	Tumor	0.3
CPT0093360003	Tumor	0.2
CPT0186100003	Tumor	0.2
CPT0228220003	Tumor	0.2
CPT0064890003	Tumor	0.2
CPT0071100003	Tumor	0.2
CPT0196850003	Tumor	0.2
CPT0167530003	Tumor	0.2
CPT0189850004	Tumor	0.1
CPT0093590003	Tumor	0.1
CPT0127420003	Tumor	0.1
CPT0204420003	Normal	0.1
CPT0189570004	Tumor	0.1
CPT0093550003	Tumor	0.1
CPT0002410011	Tumor	0.1
CPT0206450003	Tumor	0.1
CPT0217060003	Tumor	0.1
CPT0217710008	Tumor	0.1
CPT0217100003	Tumor	0.1
CPT0089150003	Tumor	0.1
CPT0216920008	Tumor	0.1
CPT0182500003	Tumor	0.1
CPT0204390003	Normal	0.0
CPT0123530003	Tumor	0.0
CPT0208980003	Tumor	0.0
CPT0092440003	Tumor	0.0
CPT0204400003	Normal	0.0
CPT0217880003	Tumor	0.0
CPT0168590003	Tumor	0.0
CPT0204410003	Normal	0.0
CPT0204350003	Normal	0.0
CPT0218690004	Tumor	0.0
CPT0182550003	Tumor	0.0
CPT0167640003	Tumor	0.0
CPT0127480003	Tumor	0.0
CPT0093510003	Tumor	-0.1
CPT0204360003	Normal	-0.1
CPT0204330003	Normal	-0.1
CPT0087680003	Tumor	-0.1
CPT0204340003	Normal	-0.1
CPT0201710003	Tumor	-0.1
CPT0199770003	Tumor	-0.1
CPT0217190003	Tumor	-0.1
CPT0218670003	Tumor	-0.1
CPT0125220003	Tumor	-0.1
CPT0225760003	Tumor	-0.1
CPT0168830003	Tumor	-0.1
CPT0190360004	Tumor	-0.1
CPT0204380003	Normal	-0.1
CPT0206000004	Tumor	-0.1
CPT0204370003	Normal	-0.1
CPT0079790003	Tumor	-0.1
CPT0205890003	Tumor	-0.1
CPT0207090003	Tumor	-0.2
CPT0167970003	Tumor	-0.2
CPT0104220003	Tumor	-0.2
CPT0125510003	Tumor	-0.2
CPT0104330003	Tumor	-0.2
CPT0189750004	Tumor	-0.2
CPT0218890004	Tumor	-0.2
CPT0189250003	Tumor	-0.2
CPT0093450003	Tumor	-0.2
CPT0224390004	Tumor	-0.2
CPT0205670004	Tumor	-0.2
CPT0224540004	Tumor	-0.2
CPT0161730003	Tumor	-0.2
CPT0224600003	Tumor	-0.2
CPT0162140003	Tumor	-0.2
CPT0190240004	Tumor	-0.2
CPT0217430008	Tumor	-0.3
CPT0168480003	Tumor	-0.3
CPT0206330003	Tumor	-0.3
CPT0206670004	Tumor	-0.3
CPT0168270003	Tumor	-0.3
CPT0218830004	Tumor	-0.3
CPT0225730003	Tumor	-0.3
CPT0224330003	Tumor	-0.3
CPT0168080003	Tumor	-0.3
CPT0218330004	Tumor	-0.3
CPT0209440003	Tumor	-0.3
CPT0168720003	Tumor	-0.4
CPT0182580003	Tumor	-0.4
CPT0207030003	Tumor	-0.4
CPT0167860004	Tumor	-0.5
CPT0167750004	Tumor	-0.5
CPT0218960004	Tumor	-0.5
CPT0171580008	Tumor	-0.6
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis